Related Experiment Video
Updated: Feb 12, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
A Rare Case of Acute Promyelocytic Leukemia with ider(17)(q10)t(15;17)(q22;q21) and FLT3-ITD Mutation
Background:
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia characterized by the t(15;17)(q22;q21) translocation. Although it typically responds well to therapy, certain genetic aberrations, including ider(17)(q10)t(15;17)(q22;q21) and FLT3-ITD mutations, have unclear prognostic implications.
Methods:
A 61-year-old female patient presented with dizziness and persistent bruising. Laboratory and imaging studies revealed coagulopathy and intracranial hemorrhage. Morphological, immunophenotypic, cytogenetic, molecular, and FISH analyses confirmed APL with both ider(17)(q10)t(15;17)(q22;q21) and FLT3-ITD mutation.
Results:
Despite standard ATRA and idarubicin induction therapy, there was no improvement in leukemic burden, and the patient succumbed to worsening hemorrhage one week after emergency surgery.
Conclusions:
This case of APL with coexisting ider(17) and FLT3-ITD mutations exhibited an aggressive course and resistance to standard treatment. These findings suggest that such patients may require intensified therapeutic strategies and closer monitoring.
More Related Videos
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Point and Frameshift Mutations
Mutations in Microorganisms

